What is ImmunityBio, Inc.'s investment purchases?

ImmunityBio, Inc. (IBRX) reported investment purchases of $139.09M in Q1 2026.

How has ImmunityBio, Inc.'s investment purchases changed year-over-year?

ImmunityBio, Inc.'s investment purchases increased by 138993.0% year-over-year, from $100K to $139.09M.

What is the long-term trend for ImmunityBio, Inc.'s investment purchases?

Over 2 years (2023 to 2025), ImmunityBio, Inc.'s investment purchases has grown at a 382.7% compound annual growth rate (CAGR), from $10.36M to $241.37M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

ImmunityBio, Inc. IBRX Investment Purchases

Investment Purchases at other companies

Johnson & JohnsonJNJ

$144M-42.6%

Merck & Co.MRK

$374M-37.1%

Gilead SciencesGILD

$525M—

Summit TherapeuticsSMMT

$177.29M—

Kymera TherapeuticsKYMR

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s investment purchases?: ImmunityBio, Inc. (IBRX) reported investment purchases of $139.09M in Q1 2026.
How has ImmunityBio, Inc.'s investment purchases changed year-over-year?: ImmunityBio, Inc.'s investment purchases increased by 138993.0% year-over-year, from $100K to $139.09M.
What is the long-term trend for ImmunityBio, Inc.'s investment purchases?: Over 2 years (2023 to 2025), ImmunityBio, Inc.'s investment purchases has grown at a 382.7% compound annual growth rate (CAGR), from $10.36M to $241.37M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.